GLP-1

Reddit gives Ozempic-class drugs an early side-effect warning layer

More than 400,000 Reddit posts were turned into an early signal radar for GLP-1 drug side effects, showing how patient forums can surface what formal trials may not catch early enough.

Wegovy and Ozempic share semaglutide, but not the same rare eye-stroke signal

Wegovy, one of the most visible weight-loss drugs on the market, is now under fresh scrutiny over a rare eye event that can end in sudden vision loss.

Obesity drugs now face a harder test: what happens to blood pressure

A new meta-analysis presented at the European Congress on Obesity in Istanbul puts a sharper number on a question already reshaping cardiometabolic medicine: how much drug-assisted weight loss lowers blood pressure.

Two familiar drugs point to an earlier way to protect the heart’s rhythm

Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.

The real test for weight-loss drugs starts after the weight comes off

New research suggests a daily GLP-1 pill could help maintain results achieved with semaglutide or tirzepatide.

Hormone therapy + tirzepatide: 35% more weight loss for women over 50

Tirzepatide + hormone therapy yields 35% more weight loss for women over 50.

Ozempic’s mental health perks: real or research mirage?